Fermentalg: TP ICAP Midcap initiates buy, targets 0.6 euro

(CercleFinance.com) - TP ICAP Midcap announced on Friday that it had initiated a buy recommendation on Fermentalg, hailing the company as 'an eco-company on the road to profitability'.


As a pioneer in omega-3 derived from microalgae and in 100% natural blue dyes, we believe Fermentalg has the assets and resources to deliver on its promise of a trajectory towards operating breakeven, supported in particular by its strategic partnerships with Huvepharma and Givaudan", explains the investment services provider.

On the basis of conservative pricing assumptions, the break-even point should be exceeded by the fourth quarter of 2026', it predicts.

Its price target of 0.6 euros shows a potential upside of 100%.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.